Advertisement
Advertisement
U.S. markets open in 7 hours 28 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Guided Therapeutics, Inc. (GTHP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5443-0.0057 (-1.04%)
At close: 01:42PM EDT
Advertisement

Guided Therapeutics, Inc.

5835 Peachtree Corners East
Suite B
Norcross, GA 30092
United States
770 242 8723
https://www.guidedinc.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees5

Key Executives

NameTitlePayExercisedYear Born
Dr. Gene S. Cartwright Ph.D.CEO, Pres, Acting CFO & Director12kN/A1954
Dr. Mark L. Faupel Ph.D.COO, Sec. & Director41.37kN/A1955
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Corporate Governance

Guided Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement